Digital Health refers to the utilization of information and communication technologies in medicine and other health-related fields to control diseases and health risks and to encourage well-being. The use of electronic information and telecommunications technology to support long-distance clinical health care, patient and professional health-related education, public health, and health management is known as Telehealth. GlobalData uses proprietary data and analytics to provide a comprehensive report on the telehealth devices market, including market shares of different players within Brazil. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the telehealth market in Brazil was Teladoc Health followed by Siemens Healthineers and Philips Healthcare Informatics.
Technologies used within Telehealth include videoconferencing, the internet, store-and-forward imaging, streaming media, and terrestrial and wireless communications. The Telehealth market include Telehealth Software and Services and Telehealth Devices. The Telehealth Software and Services platform is utilized by clinicians to communicate with patients and share videos and images is telemedicine software. Telehealth devices are used to evaluate and diagnose medical conditions. The market considers real-time telemedicine (Synchronous) solutions, store-and-forward (Asynchronous) telemedicine and on-site telemedicine.
The value of the telehealth devices market within Brazil was expected to be over $8m in 2023.
For the latest complete market share analysis of telehealth device market in Brazil, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
